Angiotech Sells Sub to Roundtable's Argon Medical Devices
Canadian specialty pharmaceuticals and medical device company Angiotech Pharmaceuticals Inc. has entered into an agreement to sell its interventional products business unit to Argon Medical Devices Inc. for C$362.5 million in cash. The transaction is expected to be completed before the end of April 2013. Plano, Texas-based Argon has been a portfolio company of US private equity firm RoundTable Healthcare Partners since 2003.
27 March 2013•9 mins read
